Compare, Analyse Aventis Pharma with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs ACTAVIS (US) - Comparison Results

SANOFI INDIA     Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SANOFI INDIA   ACTAVIS
EQUITY SHARE DATA
    SANOFI INDIA
Dec-18
ACTAVIS
Dec-18
SANOFI INDIA/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs6,84013,729-   
Low Rs4,6309,209-   
Sales per share (Unadj.) Rs1,203.13,367.7-  
Earnings per share (Unadj.) Rs165.3-1,084.7-  
Cash flow per share (Unadj.) Rs209.9354.9-  
Dividends per share (Unadj.) Rs84.000-  
Dividend yield (eoy) %1.50-  
Book value per share (Unadj.) Rs963.613,890.1-  
Shares outstanding (eoy) m23.03332.60-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.83.4 140.0%   
Avg P/E ratio x34.7-10.6 -328.2%  
P/CF ratio (eoy) x27.332.3 84.6%  
Price / Book Value ratio x6.00.8 720.8%  
Dividend payout %50.80-   
Avg Mkt Cap Rs m132,0783,814,612 3.5%   
No. of employees `0003.316.9 19.5%   
Total wages/salary Rs m4,0680-   
Avg. sales/employee Rs Th8,393.866,277.4 12.7%   
Avg. wages/employee Rs Th1,232.40-   
Avg. net profit/employee Rs Th1,153.0-21,348.0 -5.4%   
INCOME DATA
Net Sales Rs m27,7081,120,088 2.5%  
Other income Rs m89721,420 4.2%   
Total revenues Rs m28,6051,141,507 2.5%   
Gross profit Rs m6,23529,352 21.2%  
Depreciation Rs m1,027478,813 0.2%   
Interest Rs m764,635 0.0%   
Profit before tax Rs m6,098-492,677 -1.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0125,652 0.0%   
Tax Rs m2,292-6,244 -36.7%   
Profit after tax Rs m3,806-360,781 -1.1%  
Gross profit margin %22.52.6 858.7%  
Effective tax rate %37.61.3 2,965.9%   
Net profit margin %13.7-32.2 -42.6%  
BALANCE SHEET DATA
Current assets Rs m15,922459,401 3.5%   
Current liabilities Rs m6,235406,402 1.5%   
Net working cap to sales %35.04.7 738.9%  
Current ratio x2.61.1 225.9%  
Inventory Days Days6420 325.0%  
Debtors Days Days2166 31.5%  
Net fixed assets Rs m7,539126,788 5.9%   
Share capital Rs m2300-   
"Free" reserves Rs m21,9620-   
Net worth Rs m22,1924,619,838 0.5%   
Long term debt Rs m01,626,813 0.0%   
Total assets Rs m29,8397,221,859 0.4%  
Interest coverage x872.1-6.6 -13,169.6%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.90.2 598.7%   
Return on assets %12.8-4.1 -311.6%  
Return on equity %17.2-7.8 -219.6%  
Return on capital %27.5-4.8 -568.3%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m4420-   
CASH FLOW
From Operations Rs m3,739400,165 0.9%  
From Investments Rs m-731219,839 -0.3%  
From Financial Activity Rs m-1,972-686,803 0.3%  
Net Cashflow Rs m1,036-66,466 -1.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 70.95 Rs / USD

Compare SANOFI INDIA With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare SANOFI INDIA With: PROCTER & GAMBLE HEALTH  AUROBINDO PHARMA  WOCKHARDT  FRESENIUS KABI ONCO.  IPCA LABS  



Today's Market

Sensex Ends 95 Points Higher; Automobile and IT Stocks Witness Buying(Closing)

Indian share markets traded rangebound throughout the day and ended marginally higher. Sectoral indices ended on a mixed note with stocks in the automobile sector.

Related Views On News

SANOFI INDIA Announces Quarterly Results (1QFY20); Net Profit Down 2.2% (Quarterly Result Update)

Jul 31, 2019 | Updated on Jul 31, 2019

For the quarter ended June 2019, SANOFI INDIA has posted a net profit of Rs 974 m (down 2.2% YoY). Sales on the other hand came in at Rs 7 bn (up 9.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (4QFY19); Net Profit Up 12.6% (Quarterly Result Update)

May 8, 2019 | Updated on May 8, 2019

For the quarter ended March 2019, SANOFI INDIA has posted a net profit of Rs 929 m (up 12.6% YoY). Sales on the other hand came in at Rs 7 bn (up 16.1% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA 2017-18 Annual Report Analysis (Annual Result Update)

Apr 16, 2019 | Updated on Apr 16, 2019

Here's an analysis of the annual report of SANOFI INDIA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SANOFI INDIA. Also includes updates on the valuation of SANOFI INDIA.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

Two Stocks to Buy in the Great Indian Festival (Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Oct 23, 2019 (Close)

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA - SHASUN PHARMA COMPARISON

COMPARE SANOFI INDIA WITH

MARKET STATS